CON vs. MEDP: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Concentra's Quiet Healthcare Business Keeps Winning
The company is growing, widening its margins, paying down debt, and paying a dividend all at the same time. Wall Street sees more upside ahead and has tagged the stock with a full Buy rating.
Concentra Group Holdings Parent: Potential Beneficiary Of Increased Injuries From Data Center Capex
Concentra Group Holdings Parent, rated BUY, has surged 78% YTD, driven by market share gains and strong operating leverage. CON beat 2Q26 earnings estimates, with revenue up 10% YoY and adjusted EBITDA up 22.5%, aided by higher patient revenue per visit. Future growth may be propelled by additional state-level workers' compensation reimbursement increases and a robust M&A pipeline.
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Are You Looking for a Top Momentum Pick? Why Concentra Group (CON) is a Great Choice
Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Concentra Group (CON) is a Great Momentum Stock: Should You Buy?
Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.
CON or MEDP: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Concentra Group Holdings Parent Q2 Earnings Call Highlights
Concentra Group Holdings Parent NYSE: CON reported higher second-quarter revenue, earnings and cash flow, while also announcing that Chief Executive Officer Keith Newton will transition to Executive Chairman on Nov. 1 and President and Chief Financial Officer Matt DiCanio will become President and CEO.
